Concepts (78)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alcoholism | 8 | 2007 | 1109 | 0.510 |
Why?
|
| Narcotic Antagonists | 4 | 2007 | 184 | 0.380 |
Why?
|
| Naltrexone | 3 | 2007 | 195 | 0.330 |
Why?
|
| Sertraline | 2 | 2006 | 62 | 0.290 |
Why?
|
| Depressive Disorder, Major | 3 | 2006 | 439 | 0.250 |
Why?
|
| Dysthymic Disorder | 1 | 2003 | 3 | 0.230 |
Why?
|
| Alcohol-Related Disorders | 1 | 2004 | 95 | 0.230 |
Why?
|
| Antidepressive Agents | 1 | 2003 | 216 | 0.210 |
Why?
|
| Alcohol Drinking | 1 | 2004 | 805 | 0.150 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 1998 | 88 | 0.150 |
Why?
|
| Central Nervous System Depressants | 2 | 2004 | 182 | 0.110 |
Why?
|
| Surveys and Questionnaires | 1 | 1998 | 2800 | 0.080 |
Why?
|
| Mental Disorders | 2 | 2004 | 659 | 0.080 |
Why?
|
| Ethanol | 2 | 2004 | 893 | 0.070 |
Why?
|
| Combined Modality Therapy | 3 | 2005 | 951 | 0.070 |
Why?
|
| Patient Compliance | 2 | 2007 | 402 | 0.070 |
Why?
|
| Middle Aged | 8 | 2007 | 21147 | 0.070 |
Why?
|
| Alleles | 2 | 2004 | 386 | 0.070 |
Why?
|
| Adult | 8 | 2007 | 21403 | 0.070 |
Why?
|
| Amlodipine | 1 | 2005 | 31 | 0.060 |
Why?
|
| Serotonin Agents | 1 | 2004 | 13 | 0.060 |
Why?
|
| GABA Agonists | 1 | 2004 | 23 | 0.060 |
Why?
|
| Motivation | 2 | 2005 | 561 | 0.060 |
Why?
|
| Calcium Channel Blockers | 1 | 2005 | 138 | 0.060 |
Why?
|
| Coenzyme A Ligases | 1 | 2004 | 25 | 0.060 |
Why?
|
| Erythema | 1 | 2004 | 18 | 0.060 |
Why?
|
| Alcohol Deterrents | 1 | 2004 | 86 | 0.060 |
Why?
|
| Alcoholics Anonymous | 1 | 2003 | 13 | 0.060 |
Why?
|
| Double-Blind Method | 2 | 2006 | 1738 | 0.060 |
Why?
|
| Membrane Transport Proteins | 1 | 2003 | 81 | 0.050 |
Why?
|
| Treatment Outcome | 5 | 2007 | 7029 | 0.050 |
Why?
|
| Anticonvulsants | 1 | 2004 | 223 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2004 | 649 | 0.050 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2004 | 266 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2003 | 301 | 0.050 |
Why?
|
| Male | 8 | 2007 | 37321 | 0.050 |
Why?
|
| Female | 8 | 2007 | 38074 | 0.050 |
Why?
|
| Humans | 11 | 2007 | 68618 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2003 | 290 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2003 | 615 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2004 | 1040 | 0.050 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2004 | 435 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2004 | 627 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2003 | 370 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2003 | 597 | 0.040 |
Why?
|
| Depressive Disorder | 1 | 2004 | 621 | 0.040 |
Why?
|
| Cocaine-Related Disorders | 1 | 2005 | 504 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2004 | 1553 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2005 | 1851 | 0.040 |
Why?
|
| Comorbidity | 3 | 2005 | 1426 | 0.030 |
Why?
|
| Time Factors | 1 | 2004 | 4655 | 0.030 |
Why?
|
| Gene Frequency | 2 | 2004 | 207 | 0.030 |
Why?
|
| Ambulatory Care | 2 | 2005 | 340 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 1998 | 2077 | 0.030 |
Why?
|
| Genotype | 2 | 2004 | 786 | 0.020 |
Why?
|
| Aged | 1 | 2004 | 14862 | 0.020 |
Why?
|
| Riboflavin | 1 | 2007 | 15 | 0.020 |
Why?
|
| Sample Size | 1 | 2007 | 79 | 0.020 |
Why?
|
| Drug Monitoring | 1 | 2007 | 107 | 0.020 |
Why?
|
| Substance Abuse Detection | 1 | 2005 | 66 | 0.020 |
Why?
|
| Niacin | 1 | 2004 | 12 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2004 | 44 | 0.010 |
Why?
|
| Arachidonic Acid | 1 | 2004 | 86 | 0.010 |
Why?
|
| Patient Dropouts | 1 | 2005 | 98 | 0.010 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2004 | 151 | 0.010 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2003 | 51 | 0.010 |
Why?
|
| Valproic Acid | 1 | 2004 | 93 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2006 | 782 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2003 | 188 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2003 | 492 | 0.010 |
Why?
|
| DNA | 1 | 2004 | 597 | 0.010 |
Why?
|
| Antipsychotic Agents | 1 | 2004 | 247 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2004 | 403 | 0.010 |
Why?
|
| Phenotype | 1 | 2003 | 947 | 0.010 |
Why?
|
| Models, Biological | 1 | 2004 | 981 | 0.010 |
Why?
|
| Cocaine | 1 | 2005 | 555 | 0.010 |
Why?
|
| United States | 1 | 2004 | 7367 | 0.010 |
Why?
|
| Animals | 1 | 2004 | 20881 | 0.000 |
Why?
|